Metabolism of SKLB-TB1001, a Potent Antituberculosis Agent, in Animals

Tuberculosis is a major global health problem, and the emergence of multidrug-resistant and extensively drug-resistant strains has increased the difficulty of treating this disease. Among the novel antituberculosis drugs in the pipeline, decaprenylphosphoryl-beta-d-ribose-2-epimerase (DprE1) inhibit...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Xiong, Lu, Gao, Chao, Shi, Yao-Jie, Tao, Xin, Peng, Cui-Ting, Rong, Juan, Liu, Kun-Lin, Lei, Qian, Zhang, Yi-Wen, Wang, Ning-Yu, Yu, Luo-Ting
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2018
Matèries:
Chemistry; Biosynthesis
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6021648/
https://ncbi.nlm.nih.gov/pubmed/29686156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02375-17
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars